CXL Ophthalmics Publishes Results of EpiSmart® Cross-Linking Phase 2 Clinical Trial for Keratoconus in Cornea
SHERBORN, Mass.--(BUSINESS WIRE)--CXL Ophthalmics today published results of the EpiSmart Cross-linking Phase 2 study for Keratoconus in Cornea.